3D Global Biotech Inc. (TPEX:6808)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
24.55
-0.15 (-0.61%)
Jun 18, 2026, 2:59 PM CST
Market Cap1.89B -55.9%
Revenue (ttm)206.74M -22.2%
Net Income66.53M -27.5%
EPS0.84 -35.4%
Shares Out 76.98M
PE Ratio29.23
Forward PEn/a
Dividend0.10 (0.41%)
Ex-Dividend Daten/a
Volume157,611
Open24.70
Previous Close24.70
Day's Range24.00 - 24.70
52-Week Range22.45 - 63.00
Beta0.23
Analystsn/a
Price Targetn/a
Earnings DateAug 11, 2026

About 3D Global Biotech

3D Global Biotech Inc. manufactures and sells medical devices for human body reconstruction. It offers artificial bone grafting; 3D bioForming; bio-dressing; 3D bioture EX; 3D printing equipment, such as 3D BioRealizer system; orthodontic aligner system under the SmileAlign name; and iMatrix, a sectional matrix kit. The company was founded in 2014 and is based in New Taipei City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 43
Stock Exchange Taipei Exchange
Ticker Symbol 6808
Full Company Profile

Financial Performance

In 2025, 3D Global Biotech's revenue was 206.74 million, a decrease of -22.19% compared to the previous year's 265.69 million. Earnings were 66.53 million, a decrease of -27.45%.

Financial Statements